Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells.

about

Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells.

Item

http://www.wikidata.org/entity/Q55267752

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Forskolin increases the effect ...... resistant breast cancer cells.

@en

Forskolin increases the effect ...... resistant breast cancer cells.

@nl

type

Item

label

Forskolin increases the effect ...... resistant breast cancer cells.

@en

Forskolin increases the effect ...... resistant breast cancer cells.

@nl

prefLabel

Forskolin increases the effect ...... resistant breast cancer cells.

@en

Forskolin increases the effect ...... resistant breast cancer cells.

@nl

P1476

Forskolin increases the effect ...... resistant breast cancer cells.

@en

P2093

Eiji Nishio

http://www.w3.org/2001/XMLSchema#string

Jun Yukitake

http://www.w3.org/2001/XMLSchema#string

Masahiro Hikichi

http://www.w3.org/2001/XMLSchema#string

Nobuhiro Harada

http://www.w3.org/2001/XMLSchema#string

Takanori Hayashi

http://www.w3.org/2001/XMLSchema#string

Toru Wakatsuki

http://www.w3.org/2001/XMLSchema#string

Toshiaki Utsumi

http://www.w3.org/2001/XMLSchema#string

P2860

CIP2A inhibits PP2A in human malignancies

A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome

The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance

Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity

The protein kinase B/Akt signalling pathway in human malignancy

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo.

Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.

Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway

NCTD promotes Birinapant-mediated anticancer activity in breast cancer cells by downregulation of c-FLIP.

P304

23451-23461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25217

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29805747

http://www.w3.org/2001/XMLSchema#string

P932

5955115

http://www.w3.org/2001/XMLSchema#string